We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Astellas Sues Roxane Labs Over Generic Version of Billion-Dollar Cancer Drug Xtandi
Astellas Sues Roxane Labs Over Generic Version of Billion-Dollar Cancer Drug Xtandi
Astellas Pharma filed suit against generics makers Roxane Laboratories, West-Ward Pharmaceuticals and Hikma Pharmaceuticals over their copycat version of Xtandi.